Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway

Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Sichao Guo, Fengwu Li, Melissa Wills, James Yip, Alexandra Wehbe, Changya Peng, Xiaokun Geng, Yuchuan Ding
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/6886752
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551181378912256
author Sichao Guo
Fengwu Li
Melissa Wills
James Yip
Alexandra Wehbe
Changya Peng
Xiaokun Geng
Yuchuan Ding
author_facet Sichao Guo
Fengwu Li
Melissa Wills
James Yip
Alexandra Wehbe
Changya Peng
Xiaokun Geng
Yuchuan Ding
author_sort Sichao Guo
collection DOAJ
description Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which promote inflammatory and apoptotic pathways, augmenting ROS production and promoting cell death. Inhibiting ischemia-induced oxidative stress would be beneficial for reducing neuroinflammation and promoting neuronal cell survival. Studies have demonstrated that chlorpromazine and promethazine (C+P) induce neuroprotection. This study investigated how C+P minimizes oxidative stress triggered by ischemic injury. Adult male Sprague-Dawley rats were subject to middle cerebral artery occlusion (MCAO) and subsequent reperfusion. 8 mg/kg of C+P was injected into the rats when reperfusion was initiated. Neurologic damage was evaluated using infarct volumes, neurological deficit scoring, and TUNEL assays. NOX enzymatic activity, ROS production, protein expression of NOX subunits, manganese superoxide dismutase (MnSOD), and phosphorylation of PKC-δ were assessed. Neural SHSY5Y cells underwent oxygen-glucose deprivation (OGD) and subsequent reoxygenation and C+P treatment. We also evaluated ROS levels and NOX protein subunit expression, MnSOD, and p-PKC-δ/PKC-δ. Additionally, we measured PKC-δ membrane translocation and the level of interaction between NOX subunit (p47phox) and PKC-δ via coimmunoprecipitation. As hypothesized, treatment with C+P therapy decreased levels of neurologic damage. ROS production, NOX subunit expression, NOX activity, and p-PKC-δ/PKC-δ were all significantly decreased in subjects treated with C+P. C+P decreased membrane translocation of PKC-δ and lowered the level of interaction between p47phox and PKC-δ. This study suggests that C+P induces neuroprotective effects in ischemic stroke through inhibiting oxidative stress. Our findings also indicate that PKC-δ, NOX, and MnSOD are vital regulators of oxidative processes, suggesting that C+P may serve as an antioxidant.
format Article
id doaj-art-4e3f750ead4d4dbfbc692bfa135a36d4
institution Kabale University
issn 1466-1861
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-4e3f750ead4d4dbfbc692bfa135a36d42025-02-03T06:04:49ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/6886752Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD PathwaySichao Guo0Fengwu Li1Melissa Wills2James Yip3Alexandra Wehbe4Changya Peng5Xiaokun Geng6Yuchuan Ding7Luhe Institute of NeuroscienceLuhe Institute of NeuroscienceDepartment of NeurosurgeryDepartment of NeurosurgeryDepartment of NeurosurgeryDepartment of NeurosurgeryLuhe Institute of NeuroscienceDepartment of NeurosurgeryCerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which promote inflammatory and apoptotic pathways, augmenting ROS production and promoting cell death. Inhibiting ischemia-induced oxidative stress would be beneficial for reducing neuroinflammation and promoting neuronal cell survival. Studies have demonstrated that chlorpromazine and promethazine (C+P) induce neuroprotection. This study investigated how C+P minimizes oxidative stress triggered by ischemic injury. Adult male Sprague-Dawley rats were subject to middle cerebral artery occlusion (MCAO) and subsequent reperfusion. 8 mg/kg of C+P was injected into the rats when reperfusion was initiated. Neurologic damage was evaluated using infarct volumes, neurological deficit scoring, and TUNEL assays. NOX enzymatic activity, ROS production, protein expression of NOX subunits, manganese superoxide dismutase (MnSOD), and phosphorylation of PKC-δ were assessed. Neural SHSY5Y cells underwent oxygen-glucose deprivation (OGD) and subsequent reoxygenation and C+P treatment. We also evaluated ROS levels and NOX protein subunit expression, MnSOD, and p-PKC-δ/PKC-δ. Additionally, we measured PKC-δ membrane translocation and the level of interaction between NOX subunit (p47phox) and PKC-δ via coimmunoprecipitation. As hypothesized, treatment with C+P therapy decreased levels of neurologic damage. ROS production, NOX subunit expression, NOX activity, and p-PKC-δ/PKC-δ were all significantly decreased in subjects treated with C+P. C+P decreased membrane translocation of PKC-δ and lowered the level of interaction between p47phox and PKC-δ. This study suggests that C+P induces neuroprotective effects in ischemic stroke through inhibiting oxidative stress. Our findings also indicate that PKC-δ, NOX, and MnSOD are vital regulators of oxidative processes, suggesting that C+P may serve as an antioxidant.http://dx.doi.org/10.1155/2022/6886752
spellingShingle Sichao Guo
Fengwu Li
Melissa Wills
James Yip
Alexandra Wehbe
Changya Peng
Xiaokun Geng
Yuchuan Ding
Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
Mediators of Inflammation
title Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_full Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_fullStr Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_full_unstemmed Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_short Chlorpromazine and Promethazine (C+P) Reduce Brain Injury after Ischemic Stroke through the PKC-δ/NOX/MnSOD Pathway
title_sort chlorpromazine and promethazine c p reduce brain injury after ischemic stroke through the pkc δ nox mnsod pathway
url http://dx.doi.org/10.1155/2022/6886752
work_keys_str_mv AT sichaoguo chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT fengwuli chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT melissawills chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT jamesyip chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT alexandrawehbe chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT changyapeng chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT xiaokungeng chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway
AT yuchuanding chlorpromazineandpromethazinecpreducebraininjuryafterischemicstrokethroughthepkcdnoxmnsodpathway